RNA-based drugs and regulation: Toward a necessary evolution of the definitions issued from the European union legislation

Many RNA-based drugs, both vaccines and non-vaccines, are under development or even approved. They include coding mRNAs and non-coding (nc) RNAs among them antisense oligonucleotides (ASOs), small interfering RNAs (siRNAs), micro-RNAs (miRNAs), small activating RNAs (saRNAs), RNA aptamers and RNA gu...

Descripción completa

Detalles Bibliográficos
Autores principales: Guerriaud, Mathieu, Kohli, Evelyne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618588/
https://www.ncbi.nlm.nih.gov/pubmed/36325384
http://dx.doi.org/10.3389/fmed.2022.1012497

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618588/
https://www.ncbi.nlm.nih.gov/pubmed/36325384
http://dx.doi.org/10.3389/fmed.2022.1012497

Ejemplares similares